JA-William Brumskine - The Aurum Institute

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Scriba, T.J., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Mendelsohn, S.C., Hadley, K., Hikuam, C., Kaskar, M. and Musvosvi, M., 2021. Biomarker-guided tuberculosis ...
Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults.

Gray, G.E., Bekker, L.G., Laher, F., Malahleha, M., Allen, M., Moodie, Z., Grunenberg, N., Huang, Y., Grove, D., Prigmore, B. and Kee, J.J., 2021. Vaccine efficacy of ALVAC-HIV and bivalent subtype c...
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

Mendelsohn, S.C., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Hadley, K., Hikuam, C., Musvosvi, M., Bilek, N. and Erasmus, M., 2021. Validation of a host blood trans...
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Tweed, C.D., Wills, G.H., Crook, A.M., Amukoye, E., Balanag, V., Ban, A.Y.L., Bateson, A.L.C., Betteridge, M.C., Brumskine, W., Caoili, J. and Chaisson, R.E., 2021. A partially randomised trial of pre...
Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Moodie, Z., Dintwe, O., Sawant, S., Grove, D., Huang, Y., Janes, H., Heptinstall, J., Laher Omar, F., Cohen, K., De Rosa, S.C. and Zhang, L., 2022. Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine tr...
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Churchyard, G., Cárdenas, V., Chihota, V., Mngadi, K., Sebe, M., Brumskine, W., Martinson, N., Yimer, G., Wang, S.H., Garcia-Basteiro, A.L. and Nguenha, D., 2021. Annual tuberculosis preventive thera...

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults.

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Popular Tags

Most Read

Recent Posts